15 Results for "

hepsin

" in MedChemExpress (MCE) Product Catalog:
Products (15)

15 Results for "hepsin" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-114363A
CAS No.: 1832686-44-8
Purity:  98.53%
Target:  

c-Met/HGFR

Research Areas:  

Cancer

SRI 31215 (TFA) is a Matriptase/Hepsin/hepatocyte growth factor activator (HGFA) triplex inhibitor and mimics the activity of HAI-1/2 (endogenous inhibitors of HGF activation). SRI 31215 has potent inhibitory activity against matriptase, hepsin and HGFA with IC50 values of 0.69 μM, 0.65 μM and 0.30 μM, respectively. SRI 31215 can be used for the research of cancer .
loading...
    loading...
Cat. No.: HY-118134
CAS No.: 64369-13-7
Purity:  99.34%
Target:  

Ser/Thr Protease

Research Areas:  

Cancer

Hepln-13 is a potent and orally active Hepsin inhibitor with an IC50 of 0.33 μM. Hepln-13 can be used for the research of metastatic prostate cancer .
loading...
    loading...
Cat. No.: HY-P990429

Target:  

Ser/Thr Protease

Research Areas:  

Inflammation/Immunology

Anti-Hepsin Antibody is a CHO-expressed human antibody that targets Hepcidin.
loading...
    loading...
Cat. No.: HY-114363
CAS No.: 1832686-43-7
Target:  

c-Met/HGFR

Research Areas:  

Cancer

SRI 31215 is a Matriptase/Hepsin/hepatocyte growth factor activator (HGFA) triplex inhibitor and mimics the activity of HAI-1/2 (endogenous inhibitors of HGF activation). SRI 31215 has potent inhibitory activity against matriptase, hepsin and HGFA with IC50 values of 0.69 μM, 0.65 μM and 0.30 μM, respectively. SRI 31215 can be used for the research of cancer .
loading...
    loading...
Cat. No.: HY-161370
CAS No.: 2574390-19-3
Target:  

Ser/Thr Protease

Research Areas:  

Cancer

VD4162 (Compound 8b) is a macrocyclic inhibitor of serine proteases. VD4162 can significantly improve potency for all four target enzymes TMPRSS2 (IC50 = 3.7 nM), HGFA(IC50 = 3.3 nM), matriptase (IC50 = 2.9 nM), and hepsin (IC50 = 0.54 nM). VD4162 can be used for the research of cancer .
loading...
    loading...
Cat. No.: HY-161371
CAS No.: 3058672-63-9
Target:  

Ser/Thr Protease

Research Areas:  

Cancer

VD5123 is a serine protease inhibitor. VD5123 inhibits TMPRS2, HGFA, matriptase, hepsin with IC50s of 15, 3980, 140, 37 nM respectively. VD5123 can be used for antiviral research, such as SARS-CoV-2 and broad panel of coronaviruses and influenza viruses .
loading...
    loading...
Cat. No.: HY-121282B
CAS No.: 24360-97-2
Synonyms: Pecazine acetate
Target:  

Apoptosis MALT1

Research Areas:  

Others

Mepazine acetate (Pecazine acetate) is a drug that has the activity to inhibit the protease activity of MALT1. Mepazine acetate is often used to study the role of MALT1 in biology. Treatment of mouse bone marrow precursor cells with mepazine acetate strongly inhibited RANK ligand (RANKL)-induced osteoclast formation. Mepazine acetate also inhibited the expression of multiple osteoclast markers such as TRAP, feline hepsin K, and calcitonin. The protective effect of mepazine acetate was not affected by MALT1 deficiency. The mechanism of action of mepazine acetate may involve MALT1-independent mechanisms, and this aspect needs to be considered in future studies .
loading...
    loading...
Cat. No.: HY-145263
CAS No.: 2574389-19-6
Target:  

Ser/Thr Protease

Research Areas:  

Cancer

VD2173 is a side chain cyclized macrocyclic peptide inhibitor of HGF-activating serine proteases. VD2173 potently inhibits matriptase and hepsin. VD2173 can be used for the research of lung cancer .
loading...
    loading...
Cat. No.: HY-119467
CAS No.: 1366240-73-4
Target:  

Ser/Thr Protease

Research Areas:  

Cancer

MDK0734 is a selective inhibitor that inhibits feline hepsin B endopeptidase and exopeptidase activities. MDK0734 demonstrated efficacy in a cell-based in vitro tumor invasion model, significantly attenuating the invasive ability of MCF-10A neoT cells. MDK0734 provides new potential inhibitors for the development of clinically useful compounds targeting the deleterious effects of feline hepsin B in cancer progression .
loading...
    loading...
Cat. No.: HY-116264
CAS No.: 1417737-67-7
Target:  

Ser/Thr Protease

Research Areas:  

Cancer

CatB-IN-1 is an enzyme inhibitor with significant inhibitory activity against tumor invasion. CatB-IN-1 may reduce the invasiveness of tumor cells by regulating intracellular protein metabolism. CatB-IN-1 demonstrates effective anti-invasive ability in cell models and can significantly reduce the invasive ability of MCF-10A neoT cells. The structure-activity relationship study of CatB-IN-1 shows that its design can target multiple functions of cat hepsin B .
loading...
    loading...
Cat. No.: HY-19145
CAS No.: 135704-06-2
Synonyms: CI-992
Target:  

Renin

Research Areas:  

Cancer

PD-134672 (CI-992) is a renin inhibitor containing a 2-amino-4-thiazolyl substituent. PD-134672 potently inhibits monkey renin in vitro and only weakly inhibits the related aspartic protease bovine feline hepsin D. The compound exhibits oral hypotensive activity in hyperreninemic normotensive monkeys. Based on its superior efficacy and long-lasting effects in vitro and in the normotensive macaque model, PD-134672 was selected for further evaluation in renal hypertensive monkeys.
loading...
    loading...
Cat. No.: HY-P77961
Purity:  ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: Hpxn; FLJ56652; Hemopexin; HPX; HX; hepsin; HPN; TMPRSS1
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P77693
Purity:  ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: Hpxn; FLJ56652; Hemopexin; HPX; HX; hepsin; HPN; TMPRSS1
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P77693Y
Purity:  ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: Hpxn; FLJ56652; Hemopexin; HPX; HX; hepsin; HPN; TMPRSS1
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-179708
CAS No.: 3086979-57-6
Research Areas:  

Infection

Cbz-QFR-kbt is a ketone-based benzothiazole ketone inhibitor of TMPRSS2, with an IC50 value of 0.42 nM. Cbz-QFR-kbt also has inhibitory activity against Matriptase, Hepsin, HGFA, and Factor Xa, with IC50 values of 1, 1.3, 85, and 85 nM respectively. Cbz-QFR-kbt shows significant inhibitory effects against SARS-CoV-2 and H1N1 (IC50 = 60 nM). Cbz-QFR-kbt can be used in antiviral research .
loading...
    loading...
  • 1